Immune checkpoint inhibitor-induced acquired haemophilia: A pharmacovigilance analysis of the FDA adverse event reporting system.

Autor: Moore DC; Atrium Health, Department of Pharmacy, Levine Cancer Institute, Charlotte, North Carolina, USA., Elmes JB; Atrium Health, Department of Pharmacy, Levine Cancer Institute, Concord, North Carolina, USA., Arnall JR; Atrium Health, Specialty Pharmacy Service, Charlotte, North Carolina, USA., Strassels SA; Department of Pharmacy, Atrium Health, Charlotte, North Carolina, USA., Patel JN; Atrium Health, Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Charlotte, North Carolina, USA.
Jazyk: angličtina
Zdroj: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Sep; Vol. 28 (5), pp. e145-e148. Date of Electronic Publication: 2022 Jul 27.
DOI: 10.1111/hae.14632
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje